Article: Bellwether Report.com is Doing Due-Diligence on Advancis Pharmaceutical Corp.

M2 PRESSWIRE-5 October 2006-bellwetherreport.com: Bellwether Report.com is Doing Due-Diligence on Advancis Pharmaceutical Corp.(C)1994-2006 M2 COMMUNICATIONS LTD

RDATE:05102006

Bellwether Report Takes Notice of Advancis Pharmaceutical Corp. (Nasdaq:AVNC)

The company is developing new formulations of existing antibiotics that are no longer patent protected, using its PULSYS once-a-day pulsatile delivery technology. Among the antibiotics that the company is researching are amoxicillin, cephalexin, and clarithromycin. Advancis is looking to collaborate with other drugmakers to use its PULSYS technology; the company already has made a deal with Eli ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!